Drug Pipeline

VRT106 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
1
Phase 3
2
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-05-15 NCT07589244 A Study of VRT106, Combined With Camrelizumab, and Apatinib for Advanced HCC Phase 2/3 Recruiting
Active Studies by Phase
Phase 2/3
1
Phase 2
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07589244 A Study of VRT106, Combined With Camrelizumab, and Apatinib for Advanced HCC HCC Recruiting
Phase 2
NCT07486310 Evaluation of Pressurized Intraperitoneal Aerosol Chemotherapy With VRT106 Versus PIPAC… Advanced Gastric Cancer Not Yet Recruiting
Phase 1/2
NCT07093814 A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma Glioblastoma Recruiting
Phase 1
NCT06368921 A Study of Recombinant Oncolytic Virus M1(VRT106) in Patients With Solid Tumors Solid Tumor Recruiting
Sponsors Running VRT106 Trials
Guangzhou Virotech Pharmaceutical Co., Ltd. (3) Guangdong Provincial People's Hospital (1)
Disease Areas
Glioblastoma (1) Gastric Cancer (1) Liver Cancer (1)
Get alerts when VRT106 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free